ABUS icon

Arbutus Biopharma

126 hedge funds and large institutions have $88.4M invested in Arbutus Biopharma in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

1.29% more ownership

Funds ownership: 29.78%31.07% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

26% less capital invested

Capital invested by funds: $119M → $88.4M (-$30.7M)

Holders
126
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.95M
Puts
$1.25M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$14.3M
2
$10.8M
3
$10.1M
4
$9.48M
5
$6.7M
6
$3.84M
7
$3.84M
8
$3.82M
9
$3.62M
10
$2.61M
11
$1.96M
12
$1.72M
13
$1.47M
14
$1.24M
15
$828K
16
$809K
17
$751K
18
$736K
19
$623K
20
$553K
21
$549K
22
$485K
23
$420K
24
$405K
25
$383K